参考文献/References:
[1] Knoers NV, Levtchenko EN. Gitelman syndrome[J].Orphanet J Rare Dis,2008,3:22.DOI:10.1186/1750-1172-3-22.
[2] Tago N,Kokubo Y,Inamoto N,et al.A high prevalence of Gitelman's syndrome mutations in Japanese[J].Hypertens Res,2004,27(5):327-331.
[3] 董晖,郎艳华,邵泽平,等.Gitelman综合征合并甲状腺疾病:两例患者SLC2A3基因分析[J].中华内分泌代谢杂志,2010,26(5):395-398. DOI:10.3760/cma.j.issn.1000-6699.2010.05.015.
[4] Mizokami T,Hishinuma A,Kogai T,et al.Graves' disease and Gitelman syndrome[J].Clin Endocrinol(Oxf),2016,84(1):149-150.DOI:10.1111/cen.12829.
[5] 祝洁,袁晓岚,张曼娜,等.三例Gitelman综合征患者临床特点及基因突变分析[J].中华内分泌代谢杂志,2016,32(7):590-593. DOI:10.3760/cma.j.issn.1000-6699.2016.07.013.
[6] 石然然,李丛丛,方丽,等.Gitelman综合征的临床及基因诊断[J].中华内科杂志,2017,56(2):104-111.DOI:10.3760/cma.j.issn.0578-1426.2017.02.005.
[7] Baldane S,Ipekci SH,Celik S,et al.Hypokalemic paralysis due to thyrotoxicosis accompanied by Gitelman's syndrome[J]. Indian J Nephrol,2015,25(2):103-105.DOI:10.4103/0971-4065.140719.
[8] Zha B,Zheng P,Liu J,et al.Coexistence of Graves' disease in a 14-year-old young girl with Gitelman syndrome[J].Clin Endocrinol(Oxf),2015,83(6):995-997. DOI:10.1111/cen.12800.
[9] Blanchard A,Vargas-Poussou R,Vallet M,et al.Indomethacin, amiloride, or eplerenone for treating hypokalemia in Gitelman syndrome[J].J Am Soc Nephrol,2015,26(2):468-475. DOI:10.1681/ASN.2014030293.
[10] Gitelman综合征诊治专家共识协作组.Gitelman综合征诊治专家共识[J].中华内科杂志,2017,56(9):712-716. DOI:10.3760/cma.j.issn.0578-1426.2017.09.021.